COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

OLAParib COmbinations (OLAPCO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02576444
Recruitment Status : Active, not recruiting
First Posted : October 15, 2015
Last Update Posted : May 22, 2020
Dana-Farber Cancer Institute
Vanderbilt-Ingram Cancer Center
The Cleveland Clinic
Information provided by (Responsible Party):
Joseph Paul Eder, Yale University

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : October 2020
Estimated Study Completion Date : December 2020